The most common (≥20%) any-grade treatment-related TEAEs were anemia (46.7% [7/15]), decreased neutrophil count (46.7% [7/15]), decreased white blood cell count (46.7% [7/15]), elevated alanine aminotransferase (33.3% [5/15]), elevated aspartate aminotransferase (33.3% [5/15]), decreased lymphocyte count (33.3% [5/15]), and decreased platelet count (33.3% [5/15]). This evidence concerns the gene GPT and anemia (phenotype).